We are live on ! Find out more
TMDX icon

Transmedics

179 hedge funds and large institutions have $1.18B invested in Transmedics in 2022 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 53 increasing their positions, 44 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 18

68% more call options, than puts

Call options by funds: $24.1M | Put options by funds: $14.4M

64% more capital invested

Capital invested by funds: $718M → $1.18B (+$462M)

34% more funds holding

Funds holding: 134179 (+45)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

20% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 44

8.75% more ownership

Funds ownership: 81.73%90.48% (+8.7%)

Holders
179
Holders Change
+45
Holders Change %
+33.58%
% of All Funds
3.08%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
64
Increased
53
Reduced
44
Closed
18
Calls
$24.1M
Puts
$14.4M
Net Calls
+$9.74M
Net Calls Change
+$934K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$164M -$11.2M -256,961 -6%
BlackRock
2
BlackRock
New York
$91.8M +$13.2M +304,600 +16%
Macquarie Group
3
Macquarie Group
Australia
$73.1M -$3.25M -74,636 -4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$68.7M +$9.06M +208,377 +15%
SCP
5
Sandhill Capital Partners
New York
$56.1M -$10.6M -244,394 -15%
CS
6
Credit Suisse
Switzerland
$48.6M -$14.1M -325,325 -22%
DCM
7
Driehaus Capital Management
Illinois
$41.6M +$16.6M +381,688 +62%
SPPAM
8
Summit Partners Public Asset Management
Massachusetts
$34.5M +$33.6M +773,570 +1,447%
NCGI
9
Next Century Growth Investors
Minnesota
$33.6M -$3.99M -91,782 -10%
Lord, Abbett & Co
10
Lord, Abbett & Co
New Jersey
$32.2M +$33.6M +772,073 New
State Street
11
State Street
Massachusetts
$29M +$1.6M +36,716 +6%
BG
12
Bellevue Group
Switzerland
$27.3M +$3.22M +73,927 +13%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$26.7M -$1.93M -44,437 -7%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$22.7M +$2.75M +63,265 +13%
EA
15
Emerald Advisers
Pennsylvania
$20.7M +$4.23M +97,361 +24%
FAM
16
Fred Alger Management
New York
$18.2M +$19M +435,848 New
KCM
17
Kornitzer Capital Management
Kansas
$16.4M -$5.2M -119,468 -23%
EMFAT
18
Emerald Mutual Fund Advisers Trust
Pennsylvania
$16M +$1.61M +37,098 +11%
OAM
19
Ophir Asset Management
Australia
$15.8M +$16.5M +379,592 New
Morgan Stanley
20
Morgan Stanley
New York
$15.4M +$13.4M +307,301 +502%
Invesco
21
Invesco
Georgia
$14.2M +$4.82M +110,809 +48%
Axa
22
Axa
France
$14M -$281K -6,452 -2%
Allspring Global Investments
23
Allspring Global Investments
North Carolina
$13.8M +$14.3M +327,949 +19,816%
Northern Trust
24
Northern Trust
Illinois
$12.8M +$1.25M +28,667 +10%
APM
25
Avidity Partners Management
Texas
$12.5M +$13M +300,000 New

TMDX Hedge Fund Activity: Q3 2022 in Review

179 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q3 2022, worth a combined $1.18B — up 64% from $718M a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new TMDX positions and 18 closed out — a net gain of 46 holders — while 53 added to existing stakes and 44 trimmed.

The largest buyer was Summit Partners Public Asset Management, adding an estimated $33.6M. The largest seller was Credit Suisse, cutting an estimated $14.1M.

  • 179 institutional investors held Transmedics (TMDX) as of Q3 2022, up from 134 in Q2 2022.
  • Funds reported $1.18B of Transmedics stock for Q3 2022, up 64% quarter-over-quarter.
  • 64 funds opened new Transmedics positions in Q3 2022 and 18 closed out, a net change of +46 holders.
  • The largest Transmedics buyer in Q3 2022 was Summit Partners Public Asset Management, an estimated $33.6M added.
  • The largest Transmedics seller in Q3 2022 was Credit Suisse, an estimated $14.1M sold.

Based on aggregated 13F filings for Q3 2022.